August 4, 2026
Created by Daniel Cross

High Hematocrit on TRT: Safe Levels & 6 Ways to Lower It

TRT & HORMONES · SIDE EFFECTS

HIGH HEMATOCRIT ON TRT: SAFE LEVELS & 6 WAYS TO LOWER IT

High hematocrit on TRT is the most common lab change testosterone causes. It is also the one most likely to get your dose cut or therapy paused. The fixes are graded, and most men never need to jump straight to having blood drawn off.

This guide covers the safe range for hematocrit on TRT and why injections push it up most. It also shows how to lower hematocrit on TRT step by step, and what the clot evidence really shows. Every figure comes from a PubMed abstract, the guideline or the gel label, listed at the end. Testing is covered in TRT bloodwork.

D
Daniel Cross
Hormones and PED Education Editor · Updated October 2026

High hematocrit on TRT in three numbers

Three numbers frame high hematocrit on TRT. The action line, how much injections raise it, and how often heart and clot events showed up above 52 percent.

54%action line

Where guidance says reduce or stop testosterone

A urology consultation guide says to decrease or stop therapy above 54 percent until hematocrit normalizes (PMID 36335038).

+4.4points, shots

Hematocrit rise on weekly injections in 16 weeks

In matched men, injections raised hematocrit 4.4 points, pellets 1.7, and nasal gel lowered it 0.8 (PMID 37068153).

1.35xodds of events

Heart or clot events with hematocrit 52% or more

In the first year of TRT, men who reached 52 percent had more heart and clot events than matched men who did not (PMID 35050717).

Every figure here comes from a PubMed abstract, the Endocrine Society guideline or the AndroGel label, listed at the end. Lines marked rule of thumb are common practice, not study results. This page is education, not medical advice.

What this hematocrit on TRT guide covers

Covered

Safe levels: the 52 and 54 percent lines and why they are fuzzier than they look.

How to lower hematocrit on TRT: 6 steps, from a retest to phlebotomy.

Risk: what the clot and heart data do and do not show.

Not covered

Steroid cycles. See do steroids cause high hematocrit.

The marker basics. See hematocrit and hemoglobin explained.

What is a safe hematocrit on TRT?

Hematocrit is the share of your blood volume taken up by red cells. Hematocrit on TRT is checked on a schedule for that reason. Testosterone raises it in most men, and the labels and guidelines set lines for when to act.

The gel label checks hematocrit before starting, at 3 to 6 months, then yearly. If it becomes elevated, therapy stops until it falls to an acceptable level (AndroGel label).

The Endocrine Society defines erythrocytosis as hematocrit above 54 percent (Endocrine Society guideline, PMID 29562364). A 2023 consultation guide says to decrease or stop testosterone above 54 percent until it normalizes (PMID 36335038).

Here is the honest part. A 2022 review found little evidence that hematocrit itself causes harm on TRT, and called the guideline cutoffs arbitrarily chosen (PMID 34987178).

54%Hematocrit above which guidance says to reduce or pause testosterone until it normalizes (PMID 36335038).
YouWhat this means for you. Treat 52 and 54 percent as traffic lights, not a cliff edge. A single 53 percent is a reason to look closer, not to panic.

Why TRT raises hematocrit, and why injections raise it most

The rise in hematocrit on TRT has a clear mechanism. In older men on testosterone gel, hemoglobin and hematocrit rose 7 to 10 percent in 6 months. Erythropoietin, the hormone that drives red cell production, went up (PMID 24158761).

Hepcidin, the hormone that locks iron away, went down. That frees iron for new red cells. The authors described a new, higher set point for red cells (PMID 24158761).

The rise is dose dependent and larger in older men (PMID 18160461). Short acting injections carry the highest risk of any form (PMID 28526632).

Hematocrit on TRT by delivery form: what the comparisons found.
StudyWhat was comparedResult
Reddy 2023Matched men, 16 weeksInjections +4.4 points, pellets +1.7, nasal gel minus 0.8 (PMID 37068153)
Pastuszak 2015Hematocrit over 50 percent, up to 3 yearsInjections 66.7%, pellets 35.1%, gels 12.8% (PMID 26468380)
Dobs 1999Shots every 2 weeks vs patchAbnormal rises 43.8% vs 15.4% (PMID 10522982)
Calof 200519 trials, men over 45Odds of hematocrit over 50 percent 3.69 times placebo (PMID 16339333)

The pattern is the same in every study: steady low dose forms raise hematocrit less than a big weekly or two weekly spike. Timing is covered in TRT injection frequency.

YouWhat this means for you. The delivery method is the biggest lever you have. The same hormone as a spike or as a steady level does different things to your red cells.

Why some men get high hematocrit on TRT and others do not

Two men on the same plan can land far apart on hematocrit on TRT. A 20 year study of 1,073 transgender men on testosterone found clear risk factors for hematocrit over 50 percent (PMID 33599731).

Risk factors for hematocrit over 50 percent on testosterone (PMID 33599731).
FactorOdds ratio
Smoking2.2
Long acting undecanoate injections2.9
Higher BMI3.7
Lung conditions linked to erythrocytosis2.5

Most of the rise came in the first year, from 0.39 to 0.45. Yet the chance of erythrocytosis kept climbing, from 10 percent at 1 year to 38 percent at 10 years (PMID 33599731).

Untreated severe sleep apnea is a reason not to start TRT (Endocrine Society guideline, PMID 29562364). Rule of thumb: if you snore or wake unrefreshed, ask about a sleep study early.

High hematocrit on TRT risk factors: young physique athlete in running gear on a city bridge at sunrise drinking from a water bottle before a run
Smoking and higher BMI both raised the odds of high hematocrit on testosterone in a 20 year study.
YouWhat this means for you. If your hematocrit on TRT keeps climbing, look past the dose too: smoking, weight and sleep can each push it up.

Dehydration and draw timing can fake a high reading

Hematocrit on TRT is a concentration. Anything that lowers the water in your blood raises the percentage without adding a single red cell.

Rule of thumb: before acting on one high result, repeat it under steady conditions.

Standardize the next draw: rule of thumb checklist.
StepWhy
Drink normally the day before and that morningLow plasma volume inflates the number
Skip hard training and sauna for a dayFluid loss shifts the reading
Same point in the injection cycle each timePeaks drive red cell production
Mention any recent blood donationDonation lowers the reading for a while
YouWhat this means for you. One high hematocrit on TRT is a prompt to recheck, not a verdict. A clean recheck spares many men an unneeded dose cut.

How to lower hematocrit on TRT: 6 ways, in order

How to lower hematocrit on TRT is a ladder. You climb only as far as you need, with your prescriber.

1. Recheck under steady conditions. Rule of thumb: rule out a dehydration artefact first.

2. Split the dose. This is often the first real step in how to lower hematocrit on TRT. Peaks drive red cell production, and short acting injections carry the highest risk (PMID 28526632). Smaller, more frequent shots lower the peak.

3. Lower the total dose. The hematocrit rise is dose dependent (PMID 18160461). The gel label stops therapy until hematocrit settles (AndroGel label).

4. Switch to a gel or another form. Gels caused the least erythrocytosis in one comparison (PMID 26468380), and nasal gel lowered hematocrit in another (PMID 37068153).

5. Fix what you can. Smoking and higher BMI raised the odds (PMID 33599731). The authors advised quitting smoking, going transdermal and losing weight as a first step.

6. Phlebotomy, as a last resort. Evidence that it is effective or safe for testosterone induced erythrocytosis is lacking (PMID 39212549). More below.

How to lower hematocrit on TRT: young classic physique athlete in a bathroom rubbing a clear gel onto his upper arm and shoulder from his palm, towel over the other shoulder
Gels and other steady forms raised hematocrit less than weekly injections in head to head comparisons.
YouWhat this means for you. For most men the lasting fix for high hematocrit on TRT is dose, frequency or form. Those lower the stimulus, so the number stops coming back.

Phlebotomy and blood donation are not a free fix

Removing blood lowers high hematocrit on TRT fast. But a 2024 review found no solid evidence that phlebotomy is effective or safe for testosterone induced erythrocytosis (PMID 39212549).

The same review warned that phlebotomy lowers tissue oxygen and drains iron, which could switch on pathways that raise clot risk (PMID 39212549).

Donation alone did not keep hematocrit under 54 percent in men on TRT. In 44 percent of repeat donors it stayed high (PMID 28150363).

In a trial of 20,757 donors, shorter gaps between donations lowered ferritin, the iron store marker. In men it fell 6.5 percent per week shorter (PMID 31383583).

44%Repeat blood donors on TRT whose hemoglobin stayed high despite donating (PMID 28150363).
YouWhat this means for you. Do not drain blood on autopilot to manage hematocrit on TRT. If phlebotomy is used, ferritin should be tracked, and the dose should be fixed so it is needed less.

Does high hematocrit on TRT raise clot and heart risk?

The evidence on high hematocrit on TRT points in more than one direction, so here it is straight.

First year on TRT: heart and clot events5,842 matched pairs. Polycythemia defined as hematocrit 52 percent or more.Hematocrit 52%+5.15%Normal hematocrit3.87%Odds ratio 1.35. Observational database study, so it shows a link, not proof of cause.Source: Ory 2022 (PMID 35050717).
First year on TRT:heart and clot events5,842 matched pairs.High = hematocrit 52% or more.Hematocrit 52%+5.15%Normal hematocrit3.87%Odds ratio 1.35, observational.Source: PMID 35050717.

A database study matched 5,842 men on TRT who reached hematocrit of 52 percent or more with men who did not. The high group had more heart and clot events in year one, odds ratio 1.35 (PMID 35050717).

In the same study, men on testosterone without polycythemia had no more events than untreated men (PMID 35050717).

TRAVERSE, the large randomized trial, found no rise in major heart events on testosterone. It did find more atrial fibrillation, acute kidney injury and pulmonary embolism (PMID 37326322).

A 2025 review concluded that the route of delivery strongly shapes the hematocrit rise and can be chosen to limit it (PMID 40126900).

YouWhat this means for you. Very high hematocrit on TRT is worth controlling. The exact line where risk climbs is not known, which argues for steady control, not panic.

Monitoring hematocrit on TRT, and when to pause testosterone

Hematocrit on TRT: monitoring and action points.
WhenWhatSource
Before startingCheck hematocritAndroGel label
3 to 6 monthsRecheck hematocritAndroGel label
YearlyRecheck hematocritAndroGel label
Above 54 percentReduce or stop testosterone until it normalizesPMID 36335038
After any changeRule of thumb: retest a few weeks later, not monthsRule of thumb

Rule of thumb: if hematocrit is very high for your dose, ask your doctor to rule out a primary blood disorder. The same goes if platelets and white cells are also up. Experimental drugs are covered in rusfertide.

Keep hematocrit on TRT in the context of the whole plan in TRT bloodwork, and blood pressure in blood pressure on TRT.

YouWhat this means for you. A high hematocrit on TRT is common and manageable. It is rarely a reason to quit therapy, and never a reason to skip the blood count.

High hematocrit on TRT: frequently asked questions

At what hematocrit should testosterone be stopped?

Guidance says to reduce or stop testosterone above 54 percent until hematocrit normalizes (PMID 36335038). The gel label stops therapy until it falls to an acceptable level (AndroGel label).

Is a hematocrit of 52 dangerous on TRT?

Not by itself. A review called the cutoffs arbitrary (PMID 34987178). Men at 52 percent or more did have more heart and clot events in year one, odds ratio 1.35 (PMID 35050717).

Does gel raise hematocrit less than injections?

Yes in comparisons. Hematocrit over 50 percent occurred in 66.7 percent on injections and 12.8 percent on gels (PMID 26468380).

How do I lower hematocrit on TRT without phlebotomy?

Split or lower the dose, switch to a steadier form, stop smoking and lose weight if needed (PMID 33599731, PMID 26468380). Do it with your prescriber.

How often should hematocrit be checked on TRT?

Before starting, at 3 to 6 months, then yearly (AndroGel label).

Can dehydration cause a high hematocrit?

Rule of thumb: yes. Hematocrit is a concentration, so low plasma volume raises it. Recheck under steady conditions before acting.

Does blood donation fix high hematocrit on TRT?

Not reliably. In 44 percent of repeat donors on TRT it stayed high (PMID 28150363), and frequent donation lowers ferritin (PMID 31383583).

Why does testosterone raise hematocrit?

It raises erythropoietin and lowers hepcidin, which frees iron for red cells (PMID 24158761).

Sources and further reading

Every figure on this page comes from one of the 18 sources below. That is 17 papers checked against PubMed on 27 October 2026, plus the AndroGel 1.62% label on DailyMed. The 20 year risk factor study was done in transgender men. Lines marked rule of thumb are common practice. Reference links are dofollow to support open science.

1
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline

Verified

Bhasin S, et al. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID 29562364. The 54 percent erythrocytosis definition was checked against the full guideline text.

View on PubMed →

2
AndroGel (testosterone gel) 1.62%: Prescribing Information

Verified

DailyMed label revised October 2025. Section 5.2: check hematocrit before starting, re-evaluate at 3 to 6 months and then yearly, and stop therapy until hematocrit falls to an acceptable level if it becomes elevated.

View on DailyMed →

3
Management of Erythrocytosis in Men Receiving Testosterone Therapy: Clinical Consultation Guide

Verified

Agrawal P, et al. Eur Urol Focus. 2023;9(1):20-21. PMID 36335038.

View on PubMed →

4
Testosterone therapy and secondary erythrocytosis

Verified

White J, et al. Int J Impot Res. 2022;34(7):693-697. PMID 34987178.

View on PubMed →

5
Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point

Verified

Bachman E, et al. J Gerontol A Biol Sci Med Sci. 2014;69(6):725-35. PMID 24158761.

View on PubMed →

6
Effects of graded doses of testosterone on erythropoiesis in healthy young and older men

Verified

Coviello AD, et al. J Clin Endocrinol Metab. 2008;93(3):914-9. PMID 18160461.

View on PubMed →

7
Erythrocytosis Following Testosterone Therapy

Verified

Ohlander SJ, et al. Sex Med Rev. 2018;6(1):77-85. PMID 28526632.

View on PubMed →

8
Prevalence of secondary erythrocytosis in men receiving testosterone therapy A matched-cohort analysis of intranasal gel, injections, and pellets

Verified

Reddy R, et al. Can Urol Assoc J. 2023;17(7):E202-E207. PMID 37068153.

View on PubMed →

9
Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen

Verified

Pastuszak AW, et al. Sex Med. 2015;3(3):165-73. PMID 26468380.

View on PubMed →

10
Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men

Verified

Dobs AS, et al. J Clin Endocrinol Metab. 1999;84(10):3469-78. PMID 10522982.

View on PubMed →

11
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

Verified

Calof OM, et al. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451-7. PMID 16339333.

View on PubMed →

12
Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years

Verified

Madsen MC, et al. J Clin Endocrinol Metab. 2021;106(6):1710-1717. PMID 33599731.

View on PubMed →

13
Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?

Verified

Bond P, et al. Endocr Connect. 2024;13(10):. PMID 39212549.

View on PubMed →

14

Verified

Chin-Yee B, et al. Transfusion. 2017;57(3):578-581. PMID 28150363.

View on PubMed →

15
Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors

Verified

Kaptoge S, et al. Lancet Haematol. 2019;6(10):e510-e520. PMID 31383583.

View on PubMed →

16
Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy

Verified

Ory J, et al. J Urol. 2022;207(6):1295-1301. PMID 35050717.

View on PubMed →

17
Cardiovascular Safety of Testosterone-Replacement Therapy

Verified

Lincoff AM, et al. N Engl J Med. 2023;389(2):107-117. PMID 37326322.

View on PubMed →

18
Management of hematocrit levels for testosterone replacement patients, a narrative review

Verified

Fink J, et al. Sex Med Rev. 2025;13(2):229-236. PMID 40126900.

View on PubMed →

More from the TRT series

Four pages that sit next to hematocrit on TRT.

DISCLAIMER

Final Educational Note

This article is educational and is not medical advice. It reports what studies, the guideline and the gel label say about hematocrit on testosterone therapy. Any change to dose, form or phlebotomy belongs to your prescriber.

Persistent headache, blurred vision, chest pain, sudden breathlessness or one sided leg swelling on testosterone need a doctor at once. More guides sit on the TRT and hormones hub. Read more on the about page and in the full disclaimer.

D
Daniel Cross
Hormones and PED Education Editor. Reviews endocrine and sports medicine evidence for Muscle Science and checks every citation against PubMed before publication.